Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surendra Dasari

Showing results (321-330 of 333) with videos related to

Pageof 34
Sort By:
Gastroenterology|October 22, 2022
G9a Modulates Lipid Metabolism in CD4 T Cells to Regulate Intestinal InflammationGuilherme Piovezani Ramos, Adebowale O Bamidele, Emily E Klatt, et al.
Blood|May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphomaRebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
The Lancet. Digital Health|July 14, 2022
Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort studySeul Kee Byeon, Anil K Madugundu, Kishore Garapati, et al.
Analytical Chemistry|December 6, 2023
Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control SamplesCorey D Broeckling, Richard D Beger, Leo L Cheng, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Towards quality assurance and quality control in untargeted metabolomics studiesRichard D Beger, Warwick B Dunn, Abbas Bandukwala, et al.
Cancer Research Communications|March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Mayo Clinic Proceedings|June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 UpdateEli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Kidney International|December 14, 2023
Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosisTereza Kmochová, Kendrah O Kidd, Andrew Orr, et al.
JCI Insight|October 18, 2022
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancersTara L Hogenson, Hao Xie, William J Phillips, et al.
Blood|August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosisAldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Pageof 34

Showing results (321-330 of 333) with videos related to

Sort By:
Pageof 34
Gastroenterology|October 22, 2022
G9a Modulates Lipid Metabolism in CD4 T Cells to Regulate Intestinal InflammationGuilherme Piovezani Ramos, Adebowale O Bamidele, Emily E Klatt, et al.
Blood|May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphomaRebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
The Lancet. Digital Health|July 14, 2022
Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort studySeul Kee Byeon, Anil K Madugundu, Kishore Garapati, et al.
Analytical Chemistry|December 6, 2023
Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control SamplesCorey D Broeckling, Richard D Beger, Leo L Cheng, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
Towards quality assurance and quality control in untargeted metabolomics studiesRichard D Beger, Warwick B Dunn, Abbas Bandukwala, et al.
Cancer Research Communications|March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Mayo Clinic Proceedings|June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 UpdateEli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Kidney International|December 14, 2023
Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosisTereza Kmochová, Kendrah O Kidd, Andrew Orr, et al.
JCI Insight|October 18, 2022
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancersTara L Hogenson, Hao Xie, William J Phillips, et al.
Blood|August 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosisAldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, et al.
Pageof 34